Market revenue in 2024 | USD 38.0 million |
Market revenue in 2030 | USD 63.0 million |
Growth rate | 8.8% (CAGR from 2024 to 2030) |
Largest segment | Services |
Fastest growing segment | Services |
Historical data | 2018 - 2023 |
Base year | 2024 |
Forecast period | 2025 - 2030 |
Quantitative units | Revenue in USD million |
Market segmentation | Oligonucleotides, Equipment/Synthesizer, Reagents, Services |
Key market players worldwide | Thermo Fisher Scientific Inc, Merck KGaA, GE HealthCare Technologies Inc Common Stock, Agilent Technologies, Kaneka Corp, Heritage Global Inc, Twist Bioscience Corp, Bio-Synthesis, Biolegio |
No credit card required*
Name | Profile | # Employees | HQ | Website |
---|
The databook is designed to serve as a comprehensive guide to navigating this sector. The databook focuses on market statistics denoted in the form of revenue and y-o-y growth and CAGR across the globe and regions. A detailed competitive and opportunity analyses related to oligonucleotide synthesis market will help companies and investors design strategic landscapes.
Services was the largest segment with a revenue share of 37.89% in 2024. Horizon Databook has segmented the Norway oligonucleotide synthesis market based on oligonucleotides, equipment/synthesizer, reagents, services covering the revenue growth of each sub-segment from 2018 to 2030.
The oligonucleotide synthesis market in Norway is expected to witness steady growth over the forecast period. Growth can be attributed to the advancements in research, expanding applications, and increasing awareness of personalized medicine. Companies that navigate the challenges, adapt to the evolving landscape and develop strategic partnerships.
In addition, the growing prevalence of lung cancer in the country is expected to support market growth over the forecast period. Oligonucleotide synthesis, the process of creating short single-stranded DNA or RNA molecules, has the potential for lung cancer diagnosis, treatment, and prevention. Norway has a high prevalence of lung cancer cases.
Horizon Databook provides a detailed overview of country-level data and insights on the Norway oligonucleotide synthesis market , including forecasts for subscribers. This country databook contains high-level insights into Norway oligonucleotide synthesis market from 2018 to 2030, including revenue numbers, major trends, and company profiles.
Sign up and get instant basic access to databook, upgrade
when ready, or enjoy our
free plan indefinitely.
Included in Horizon account